New perspectives in adenoviruses

Current Clinical Topics in Infectious Diseases

Volumn , Issue 18, 1998, Pages 286-305

  Lukashok, Sophie A ^a   Horwitz, Marshall S ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA; VIRUS VACCINE;

ADENOVIRUS; AIDS RELATED COMPLEX; ALLOTRANSPLANTATION; CLASSIFICATION; GENE THERAPY; HUMAN; IMMUNE DEFICIENCY; KERATOCONJUNCTIVITIS; PHYSIOLOGY; REVIEW; VIROLOGY; VIRUS INFECTION;

ADENOVIRIDAE; ADENOVIRIDAE INFECTIONS; AIDS-RELATED OPPORTUNISTIC INFECTIONS; DNA, VIRAL; GENE THERAPY; HUMANS; IMMUNOCOMPROMISED HOST; KERATOCONJUNCTIVITIS; TRANSPLANTATION, HOMOLOGOUS; VIRAL VACCINES;

EID: 0031614808     PISSN: 01953842     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Review

References (91)

1. Rowe WP, Huebner RJ, Gilmore LK, Parrot RH, Ward TG. Isolation of a cytopathogenic agent from human adenoids undergoing spontaneous degeneration in tissue culture. Proc Soc Exp Biol Med 1955;84:570-573.
2. Schnurr D, Dondero ME. Two new candidate adenovirus serotypes. Intervirology 1993; 36:79-83.
3. Horwitz MS. Adenoviridae and their replication. In: Fields BN, Knipe DM, Chanock RM, et al, eds. Virology. 2nd ed. New York: Raven Press, 1990:1679-1721.
4. Horwitz MS. Adenoviruses. In: Gorbach SL, Bartlett JG, Blacklow NR, eds. Infectious diseases. 2nd ed. New York: W.B. Saunders, 1997:239.
5. Horwitz MS. Adenoviruses. In: Fields BN, Knipe DM, Chanock RM, et al, eds. Virology. 3rd ed. Philadelphia: Lippincott, 1996:2149-2171.
6. Fox JP, Hall CE, Cooney MK. The Seattle virus watch. VII. Observations of adenovirus infections. Am J Epidemiol 1977;105:362-396.
7. Fox JP, Brandt CD, Wassermann FE, et al. The Virus Watch Program: a continuing surveillance of viral infections in metropolitan New York families. VI. Observations of adenovirus infections: virus excretion patterns, antibody response, efficiency of surveillance, patterns of infection and relation to illness. Am J Epidemiol 1969;89:25-50.
8. Relatis P, Straye C, Harley R. The spectrum of adult adenovirus pneumonia. Chest 1996; 109:1656-1657.
9. Birenbaum E, Linder N, Varsanon A, Kvist J, Spierer A, Reichman B. Adenovirus type 8 conjunctivitis outbreak in a neonatal intensive care unit. Arch Dis Child 1993;68:610-611.
10. Azar MJ, Dhaliwal DK, Bower KS, Kowalski RP, Gordon YJ. Possible consequences of shaking hands with your patients with epidemic keratoconjunctivitis. Am J Ophthalmol 1996;121:711-712.
11. Ankers HE, Klapper PE, Cleator GM, Bailey AS, Tullo AB. The role of a rapid diagnostic test (adenovirus immune dot-blot) in the control of an outbreak of adenovirus type 8 keratoconjunctivitis. Eye 1993;7:15-17.
12. Kindrington PR, Turse SE, Kowalski RP, Gordon YJ. Use of polymerase chain amplification reaction for the detection of adenoviruses in ocular swab specimens. Invest Ophthalmol & Vis Sci 1994;35:4126-4134.
13. Ward JB, Siojo LG, Waller SG. A prospective, masked clinical trial of trifluoridine, dexamethasone and artificial tears in the treatment of epidemic keratoconjunctivitis. Cornea 1993;12:216-221.
14. Trousdale MD, Goldschmidt PL, Nobrega R. Activity of ganciclovir against human Ad5 infection in cell culture and cotton rat eyes. Cornea 1994;13:435-439.
15. Pillay D, Lipman MCI, Lei CA, Johnson MA, Griffiths BP. A clinico-pathological audit of opportunistic viral infections in HIV-infected patients. AIDS 1993;7:969-974.
16. Horwitz MS, Valderrama G, Korn R, Spigland I. Adenovirus isolates from the urines of AIDS patients: characterization of group B recombinants. In: Alan R, Liss I, eds. UCLA Symposia on Molecular and Cell Biology. 1984:187-207.
17. Horwitz MS, Valderrama G, Hatcher V, Korn R, Spigland I. Characterization of adenovirus isolates from AIDS patients. Ann NY Acad Sci 1985;437:161-174.
18. Flomenberg PR, Chen P, Munk G, Horwitz MS. The molecular epidemiology of adenovirus type 35 isolates from immunocompromised hosts. J Infect Dis 1987;155:1127-1134.
19. Hierholzer JC, Wigand R, Anderson LJ, Adrian T, Gold JWM. Adenovirus from patients with AIDS: a plethora of serotypes and a description of five new serotypes of subgenus D (types 43-47). J Infect Dis 1988;158:804-813.
20. Fiala M, Payne JE, Berne TV, Poolsawat S, Schieble J, Guze LB. Role of adenovirus type 11 in hemorrhagic cystitis secondary to immunosuppression. J Urol 1974;112:595-597.
21. Siegel FP, Dikman SH, Arayata RB, Bottone EJ. Fatal disseminated adenovirus 11 pneumonia in an agammaglobulinemic patient. Am J Med 1981;71:1062-1067.
22. Shirtaku M, Nasu K, Ito M. Necrotizing tubulo-interstitial nephritis induced by adenovirus in an AIDS patient. Histopathology 1993;23:588-590.
23. Green WR, Greaves WL, Frederick WR, Taddesse-Heale L. Renal infection due to adenovirus in a patient with human immunodeficiency virus infection. Clin Infect Dis 1994;18:989-991.
24. Cunningham AL, Grohman GS, Harkness J, Law C, Marriott D, Tindall B, Cooper DA. Gastrointestinal viral infections in homosexual men who were symptomatic and seropositive for human immunodeficiency virus. J Infect Dis 1988;158:386-391.
25. Schmidt W, Schneider T, Heise W, Weinke T, Epple HJ, Stoffler-Meilicke M, Liesenfeld O, Ignatuis R, Miekler EO, Ullriche R. Stool viruses, coinfections and diarrhea in HIV-infected patients. J Acquir Immune Defic Synd 1996;13:33-38.
26. Koneru B, Jaffe R, Esquivel CO, Todo S, Iwatsuki S, Starzl TE. Adenoviral infections in pediatric liver transplant recipients. JAMA 1987;258:489-492.
27. Shields AF, Hackman RC, Fife KH, Corey L, Meyers JD. Adenovirus infections in patients undergoing bone-marrow transplantation. N Engl J Med 1985;312:529-533.
28. Zahradnik JM, Spencer MJ, Parker DD. Adenovirus infection in the immunocompromised patient. Am J Med 1980;68:725-732.
29. South MA, Dolen J, Beach DK, Mirkovic RR. Fatal adenovirus hepatic necrosis in severe combined immune deficiency. Ped Inf Dis 1982;1:416-419.
30. Shields AF, Hackman RC, Meyers JD, Fife KH, Corey L. Fulminant liver failure induced by adenovirus after bone marrow transplantation (letter). N Engl J Med 1985;312:1707-1708.
31. Flomenbcrg P, Babbitt J, Drobyski WR, Ash RC, Carrigan DR, Sedmak GV, McAuliffe T, Camitta B, Horowitz MM, Bunin N, et al. Increasing incidence of adenovirus disease in bone marrow transplant recipients. J Infect Dis 1994;169:775-781.
32. Koneru B, Atchinson R, Jaffe R, Cassavilla A, Van Thiel DH, Starzl TE. Serological studies of adenoviral hepatitis following pediatric liver transplantation. Transplant Proc 1990;22:1547-1548.
33. Whimbey E, Champlin RE, Couch RB, Englund JA, Goodrich JM, Raad I, Przepiorka D, Lewis VA, Mirza N, Yousuf H, et al. Community respiratory virus infections among hospitalized adult bone marrow transplant recipients. Clin Infect Dis 1996;22: 778-782.
34. Myerowitz RL, Stadler H, Oxman MN, Levin MJ, Moore M, Leith JD, Gantz NM, Pellegrini J, Hierholzer JC. Fatal disseminated adenovirus infection in a renal transplant recipient. Am J Med 1975;59:591-598.
35. Pinto A, Beck R, Jadavji T. Fatal neonatal pneumonia caused by adenovirus type 35. Arch Path Lab Med 1992;116:95-99.
36. Matsuse T, Hayashi S, Kuwano K, Keunecke H, Jefferies WA, Hogg JC. Latent adenoviral infection in the pathogenesis of chronic airways obstruction. Am Rev Respir Dis 1992; 146:177-184.
37. Bateman ED, Hayashi S, Kuwano K, Wilke TA, Hogg JC. Latent adenoviral infection in follicular bronchiectasis. Am J Respir Critical Care Med 1995;155:2113-2114.
38. Hogg JC, Irving WL, Porter H, Evans M, Dunhill MS, Fleming K. In situ hybridization studies of adenoviral infections of the lung and their relationship to follicular bronchiectasis. Am Rev Respir Dis 1989; 139:1531-1535.
39. Martin AB, Weber S, Fricker FJ, Jaffe R, Demmler G, Kearney D, Zhang YH, Bodurtha J, Gelb B, Ni J, et al. Acute myocarditis. Rapid diagnosis by PCR in children. Circulation 1994;90:330-339.
40. Lozinski GN, Davis G, Kraus HF, Brillman GF, Shimizu H, Burns JC. Adenovirus myocarditis: retrospective diagnosis by gene amplification from formalin-fixed paraffin-embedded tissues. Hum Pathol 1994;25:831-834.
41. Matsuse T, Namba Y, Ikeda K, Inoue S, Hosoi T, Ouchi Y, Fukuchi Y, Orimo H. Immunohistochemical and in situ hybridization detection of the adenovirus early region 1A (E1A) gene in the microglia of human brain tissue. J Clin Path 1994;47:275-277.
42. Ginsberg HS, Lundholm-Beauchamp U, Horswood RL, Pernis B, Wold WSM, Chanock RM, Prince GA. Role of early-region 3 (E3) in pathogenesis of adenovirus disease. Proc Natl Acad Sci USA 1989;86: 3823-3827.
43. Wold WSM, Gooding LR. Region E3 of adenovirus: a cassette of genes involved in host immunosurveillance and virus-cell interactions. Virology 1991;184:1-8.
44. Sparer T, Tripp RA, Dilleha DL, Hermiston TW, Wold WS, Gooding LR. The role of human adenovirus early region 3 proteins (gp19K, 10.4K, 14.5K and 14.7K) in a murine pneumonia model. J Virol 1996;70:2431-2439.
45. Munaf A, Lemoine NR, Ring CJA. The use of DNA viruses as vectors for gene therapy. Gene Ther 1994;1:367-374.
46. Stratford-Perricaudet L, Levrero M, Chaise JF, Perricaudet M, Briand P. Evaluation of the transfer and expression in mice of an enzyme encoding gene using a human adenovirus vector. Hum Gene Ther 1990;1:241-256.
47. Haddada H, Ragot T, Cordier L, Duffour MT, Perricaudet M. Adenoviral interleukin-2 gene transfer into P815 tumour cells abrogates tumorigenicity and induces antitumoral immunity in mice. Hum Gene Ther 1993;4: 703-711.
48. Fujiwara T, Grimm EA, Mukhopadhyay T, Zhang WV, Owen-Shaub LB, Roth JA. Introduction of chemosensitivity in human lung cancer cells in vivo by adenovirus-mediated transfer of the wild-type p53 gene. Can Res 1994;54:2287-2291.
49. Chen SH, Shine HD, Goodman JC, Grossman RG, Woo SLC. Gene therapy for brain tumor: regression of experimental gliomas by adenovirus mediated gene transfer in vivo. Proc Natl Acad Sci USA 1994;91:3054-3057.
50. Smythe WR, Hwang HC, Amin KM. Use of recombinant adenovirus to transfer the herpes simplex virus thymidine kinase (HSVtk) gene to thoracic neoplasms: an effective in vitro drug sensitization system. Can Res 1994;54: 2055-2059.
51. Crystal RG, McElvaney NG, Rosenfeld MA, Chu C, Mastrangeli A, Hay JG, Brody SL, Jaffe HA, Eissa NT, Danel C. Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis. Nature Genetics 1994;8:42-50.
52. Rosenfeld MA, Yoshimura K, Trapnell BC, Yoneyama W, Fukayama M, Bargon J, Stier LE, Stratford-Perricaudet L, Perricaudet M, Guggino WB, et al. In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium. Cell 1992;68:143-155.
53. Wilmott RW, Amin RS, Perez CR, Wert SE, Keller G, Boivin GP, Hirsch R, Inocencios D, Lu P, Fleising SF, et al. Safety of adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator cDNA to the lungs of nonhuman primates. Hum Gene Ther 1996;7:301-318.
54. Yang Y, Li O, Ertl HC, Wilson JM. Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J Virol 1995;69:2004-2015.
55. van Ginkel FW, Liu C, Simecka JW, Dong JY, Greenway T, Frizzell RA, Kiyono H, McGhee JR, Pascual DW. Intratracheal gene delivery with adenoviral vector induces elevated systemic IgG and mucosal IgA antibodies to adenovirus and β-galactosidase. Hum Gene Ther 1995;6:895-903.
56. Tripathy SK, Black HB, Goldwasser E, Leiden JM. Immune responses to transgenic encoded proteins limit the stability of gene expression after infection of replication defective adenovirus vectors. Nature Medicine 1996;2:545-550.
57. Ilan Y, Jona VK, Sengupta K, et al. Transient immunosuppression with FK506 permits long-term expression of therapeutic genes introduced into the liver using recombinant adenoviruses in the rat. Hepatology 1997; 26:949-956.
58. Fang B, Eisensmith RC, Wang H, Kay MA, Cross RE, Landen CN, Gordon G, Bellinger DA, Read MS, Hu PC, et al. Gene therapy for hemophilia B: host immunosuppression prolongs the therapeutic effect of adenovirus mediated factor IX-expression. Hum Gene Ther 1995;6:1039-1044.
59. Yang Y, Trinchieri G, Wilson JM. Recombinant IL-12 prevents formation of blocking IgA antibodies to recombinant adenovirus and allows repeated gene therapy to mouse lung. Nature Medicine 1995;1:890-893.
60. Grunhaus A, Cho S, Horwitz MS. Association of vaccinia virus-expressed adenovirus E3-19K glycoprotein with class I MHC and its effects on virulence in a murine pneumonia model. Virology 1994;200:535-546.
61. Beier DC, Cox JH, Vining DR, Cresswell P, Engelhard MI. Association of human class I MHC alleles with the adenovirus E3/19K protein. J Immunol 1994;152:3862-3872.
62. Efrat S, Fejer G, Brownlee M, Horwitz MS. Prolonged survival of pancreatic islet allografts mediated by adenovirus immunoregulatory transgenes. Proc Natl Acad Sci USA 1995;92: 6947-6951.
63. Polier W, Schneider-Rasp S, Liebert U, Merklein F, Thalheimer P, Haack A, Schwaab R, Schmitt C, Brackmann HH. Stabilization of transgene expression by incorporation of E3 region genes into an adenoviral factor IX vector and by transient anti-CD4 treatment of the host. Gene Therapy 1996;3: 521-530.
64. Ilan Y, Droguett G, Roy Chowdhury N, Li Y, Sengupta K, Thummala NR, Davidson A, Roy Chowdhury J, Horwitz MS. Insertion of the adenoviral E3 region into a recombinant viral vector prevents antiviral humoral and cellular immune responses and permits long term gene expression. Proc Natl Acad Sci USA 1997;94:2587-2592.
65. Ilan Y, Prakash R, Davidson A, Jona V, Droguett G, Horwitz MS, Roy Chowdhury N, Roy Chowdhury J. Oral tolerization to adenoviral antigens permits long-term gene expression using recombinant adenoviral vectors. J Clin Invest 1997;99:1098-1106.
66. Dai Y, Schwarz EM, Gu D, Zhang WW, Sarvetnick N, Verma IM. Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows long term expression. Proc Natl Acad Sci USA 1997;92:1401-1405.
67. Takahashi M, Ilan Y, Roy Chowdhury N, Guida J, Horwitz MS, Roy Chowdhury J. Long term correction of bilirubin-UDP-glucuronosyltransferase deficiency in Gunn rats by administration of a recombinant adenovirus during the neonatal period. J Biol Chem 1996;271:1-7.
68. Kass-Eisler A, Falck-Pedersen E, Elfenbein DH, Alvira M, Buttrick PM, Leinwand LA. The impact of developmental stage, route of administration and the immune system on adenovirus-mediated gene transfer. Gene Therapy 1994;1:1-8.
69. Mittal SK, Prevec L, Graham FL, Babiuck LA. Development of a bovine adenovirus type 3 based expression vector. J Gen Virol 1995; 76(Pt 1):93-102.
70. Haecker SE, Stedman HH, Balice-Gordon RJ, Smith DB, Greelish JP, Mitchell MA, Wells A, Sweeney HL, Wilson JM. In vivo expression of full-length human dystrophin from adenoviral vectors deleted of all viral genes. Hum Gene Ther 1996;7:1907-1914.
71. Fisher KJ, Choi H, Burda J, Chen SJ, Wilson JM. Recombinant adenomus deleted of all genes for gene therapy of cystic fibrosis. Virology 1996;217:11-22.
72. Kumar-Singh R, Chamberlain JS. Encapsulated adenovirus minichromosomes allow delivery and expression of a 14kb dystrophin cDNA to muscle cells. Hum Mol Genet 1997; 5:913-921.
73. Grunhaus A, Horwitz MS. Adenoviruses as cloning vectors. In: Rice C, ed. Seminars in virology. London: Saunders Scientific Publications, 1992:237-252.
74. Gall J, Kass-Eisler A, Leinwand L, Falck-Pedersen E. Adenovirus type 5 and 7 capsid chimera: fiber replacement alters receptor tropism without affecting primary immune neutralization epitopes. J Virol 1996;70: 2116-2123.
75. Hsu KH, Lubeck MD, Davis AR, Bhat RA, Selling BH, Bhat BM, Mizutani S, Murphy BR, Collins PL, Chanock RM, et al. Immunogenicity of recombinant adenovirus-respiratory syncytial virus vaccines with adenovirus types 4, 5, and 7 vectors in dogs and a chimpanzee. J Infect Dis 1992;166:769-775.
76. Gallichan WSA, Rosenthal KL. Specific secretory immune responses in the female genital tract following intranasal immunization with a recombinant adenovirus expressing glycoprotein B of herpes simplex virus. Vaccine 1996;13:1589-1595.
77. Berencsi K, Rando RF, de Taisne C, Paoletti E, Plotkin SAA, Gonczol E. Murine cytotoxic T-cell response specific for human cytomegalovirus glycoprotein B(gB) induced by adenovirus and vaccinia virus recombinants expressing gB. J Gen Virol 1993;74 (Pt I):2507-2512.
78. Lubeck MD, Natuk RJ, Chengalvala M, Chanda PK, Murthy KK, et al. Immunogenicity of recombinant adenovirus-human immunodeficiency virus vaccines in chimpanzees following intranasal administration. AIDS Res Hum Retrovirus 1994;10:1443-1449.
79. Chanda PK, Natuk RJ, Mason BB, Bhat BM, Greenberg L, Dheer SK, Molnar-Kimber KL, Mizutani S, Lubeck MD, Davis AR, et al. High level expression of the envelope glycoproteins of the human immunodeficiency virus type I in presence of rev gene using helper-independent adenovirus type 7 recombinants. Virology 1990;175:535-547.
80. Ye WW, Mason BB, Chengalvala M, Chen S, Zandle G, Lubeck MD, Lee S, Mizutani S, Davis AR, Hung PP. Co-expression of hepatitis B virus antigens by a non-defective adenovirus vaccine vector. Arch Virol 1991; 118:11-27.
81. Morin JE, Lubeck MD, Barton JE, Conley AJ, Davis AR, Hung PP. Recombinant adenovirus induces antibody response to hepatitis B virus surface antigen in hampsters. Proc Natl Acad Sci USA 1987;84:4626-4630.
82. Chengalvala MV, Bhat BM, Bhat R, Lubeck MD, Mizutani S, Davis AR, Hung PP. Immunogenicity of high expression adeno-virus-hepatitis B virus recombinant vaccines in dogs. J Gen Virol 1994;75:125-131.
83. Makimura M, Miyake S, Akino N, Takamori K, Matsura Y, et al. Induction of antibodies against structural proteins of hepatitis C virus in mice using recombinant adenovirus. Vaccine 1996;14:28-36.
84. Zhai Y, Yang JC, Kawakami Y, Spiess P, Wadsworth SC, et al. Antigen-specific tumor vaccines. Development and characterization of recombinant adenoviruses MART1 or gp100 for cancer therapy. J Immunol 1996; 156:700-710.
85. Krasnykh UN, Mikheeva GV, Douglas JT, Curiel DT. Generation of recombinant adenovirus vectors with modified fibers for altering viral tropism. J Virol 1996;70:6839-6846.
86. Bergelson JM, Cunningham JA, Kurt-Jones E, Hong JS, Droguett G, Horwitz MS, Crowell RL, Finberg RW. Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5. Science 1997;275: 1320-1323.
87. Crystal R. Managed care for viruses. Nature Medicine 1997;3:383-384.
88. Tomko RP, Xu R, Philipson L. HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackie viruses. Proc Natl Acad Sci USA 1997;94:3352-3356.
89. Hong SS, Karayan L, Tournier J, Curiel DT, Boulanger PA. Adenovirus type 5 fiber knob binds to MHC class I a2 domain at the surface of human epithelial and B lymphoblastoid cells. EMBO 1997;16:2294-2306.
90. 5 promote adenovirus internalization but not virus attachment. Cell 1993;73:309-319.
91. Javier R, Shenk T. Mammary tumors induced by human adenovirus type 9: a role for the viral early region 4 gene. Breast Cancer Res Treat 1996;39:57-67.